('mesonephron', 0.00046140553715865004)
('euthyroid_sick_syndrome', 0.0004611437994633439)
('CST1', 0.00046113779633565104)
('fascicle', 0.0004610741235559593)
('NUP153', 0.0004609848590550409)
('cutaneous_fibrous_histiocytoma', 0.0004608491175973047)
('Kimura_disease', 0.0004607259984060797)
('ALG3', 0.000460719825532914)
('GNL3', 0.0004607151049573767)
('ADAMTS4', 0.00046067312596275215)
('EGFL6', 0.0004606622308875839)
('glycine_N-methyltransferase_deficiency', 0.00046058448432966995)
('GLY', 0.0004605825836324908)
('CD1E', 0.0004605267120332088)
('KATO-III_cell', 0.0004603635315539477)
('membrane_disassembly', 0.0004603139335899499)
('TCFL5', 0.00046024053369895525)
('COL3A1', 0.0004601016958521391)
('chromosome_condensation', 0.0004600286127668897)
('KCNJ5', 0.0004598715576759428)
('GRM4', 0.0004597881973972812)
('SERPINB3', 0.00045970673134439086)
('RIDA', 0.000459581311691293)
('MAGEC3', 0.0004593993942904229)
('MIR552', 0.00045938959212356653)
('multinodular_goiter', 0.00045934565321628645)
('PGM1', 0.0004593339571042386)
('RHPN1-AS1', 0.0004592912112553454)
('NAP1L3', 0.00045927277841333085)
('familial_febrile_seizures', 0.0004591626771034897)
('PLAAT4', 0.00045904713553052205)
('capillary_hemangioma', 0.0004590420088407369)
('ravulizumab', 0.00045901539443110037)
('TBCK', 0.0004588287352090836)
('Hippo_signaling_pathway', 0.0004585949827787679)
('neural_tissue_regeneration', 0.0004585812253054961)
('embryonal_carcinoma', 0.0004583204504745575)
('luteinizing_hormone_receptor_activity', 0.00045827672719718233)
('RPL10L', 0.0004581637704264426)
('colonic_benign_neoplasm', 0.0004581217918032123)
('LBX1', 0.00045811194834496487)
('NT5C1A', 0.00045802245510005767)
('HNRNPH3', 0.0004579232310428614)
('Fresolimumab', 0.0004577533017335401)
('RIMS2', 0.0004577211445627286)
('IgA_immunoglobulin_complex__circulating', 0.0004577196387754624)
('Brodalumab', 0.0004573777342796884)
('ZMYM3', 0.00045723916727334943)
('CCRF-CEM_cell', 0.0004571461524690651)
('Camrelizumab', 0.00045708642614941116)
('ZMPSTE24', 0.00045697384148449266)
('Demcizumab', 0.0004565897364639574)
('hydroxylamine_oxidase_activity', 0.0004565726766419735)
('ubiquitin_conjugating_enzyme_activity', 0.0004564118879007674)
('SNHG22', 0.0004563201098827544)
('PMEPA1', 0.00045618853599249133)
('TUBB4A', 0.00045606402683649104)
('endospore', 0.0004559732063925985)
('null_cell', 0.00045595976929383797)
('Sagopilone', 0.00045593106359875454)
('hereditary_spherocytosis_type_4', 0.0004558669829850266)
('NUCB1', 0.0004557671491569146)
('Somatostatin', 0.0004557650969632081)
('CARD18', 0.0004557410804857111)
('Kupffer_cell', 0.00045569474526662405)
('MHCC97-H_cell', 0.000455437424963518)
('TDP2', 0.0004553613651343525)
('Veltuzumab', 0.00045530442140470737)
('MIR2467', 0.00045527401251305193)
('SETD1A', 0.00045513574785828985)
('MIR345', 0.0004551187971646001)
('Vandetanib', 0.00045511659468305246)
('GPIHBP1', 0.0004549146851981476)
('SLCO1A2', 0.00045491165217689117)
('TRIM22', 0.0004547961847685296)
('Cobimetinib', 0.00045479580903472644)
('Raxibacumab', 0.00045479068020376907)
('MMRN2', 0.0004547794890577323)
('Bavituximab', 0.00045477106091363587)
('filariasis', 0.00045477106091363587)
('MORC1', 0.00045477106091363587)
('Mepolizumab', 0.00045477106091363587)
('SLC22A18', 0.00045477106091363587)
('lip_cancer', 0.00045475598793303425)
('basophil_degranulation', 0.0004547509638282007)
('Carotuximab', 0.0004547509638282007)
('D-Di', 0.0004547509638282007)
('Pamrevlumab', 0.0004547509638282007)
('TRAIL_death-inducing_signaling_complex_assembly', 0.0004547509638282007)
('Oregovomab', 0.0004547509638282007)
('lumen_of_tube', 0.0004547509638282007)
('COS_cell', 0.0004547509638282007)
('Jeko-1_cell', 0.0004547509638282007)
('DNA/RNA_hybrid_binding', 0.0004547509638282007)
('Edrecolomab', 0.0004547509638282007)
('Fulranumab', 0.0004547509638282007)
('POMT2', 0.0004547509638282007)
('Johnston_s_organ', 0.0004547509638282007)
('Emicizumab', 0.0004547509638282007)
('ADCY7', 0.0004547509638282007)
('trastuzumab deruxtecan', 0.0004547509638282007)
('SLIT1', 0.0004547509638282007)
('IgD_binding', 0.0004547509638282007)
('Dupilumab', 0.0004547509638282007)
('microvascular_endothelium', 0.0004545630447953826)
